Cargando…

Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries

AIM: To evaluate the effect of vaccination/booster administration dynamics on the reduction of excess mortality during COVID-19 infection waves in European countries. METHODS: We selected twenty-nine countries from the OurWorldInData project database according to their population size of more than o...

Descripción completa

Detalles Bibliográficos
Autores principales: Matveeva, Olga, Shabalina, Svetlana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357837/
https://www.ncbi.nlm.nih.gov/pubmed/37483606
http://dx.doi.org/10.3389/fimmu.2023.1151311
_version_ 1785075581181755392
author Matveeva, Olga
Shabalina, Svetlana A.
author_facet Matveeva, Olga
Shabalina, Svetlana A.
author_sort Matveeva, Olga
collection PubMed
description AIM: To evaluate the effect of vaccination/booster administration dynamics on the reduction of excess mortality during COVID-19 infection waves in European countries. METHODS: We selected twenty-nine countries from the OurWorldInData project database according to their population size of more than one million and the availability of information on dominant SARS-CoV-2 variants during COVID-19 infection waves. After selection, we categorized countries according to their “faster” or “slower” vaccination rates. The first category included countries that reached 60% of vaccinated residents by October 2021 and 70% by January 2022. The second or “slower” category included all other countries. In the first or “faster” category, two groups, “boosters faster’’ and “boosters slower” were created. Pearson correlation analysis, linear regression, and chi-square test for categorical data were used to identify the association between vaccination rate and excess mortality. We chose time intervals corresponding to the dominance of viral variants: Wuhan, Alpha, Delta, and Omicron BA.1/2. RESULTS AND DISCUSSION: The “faster” countries, as opposed to the “slower” ones, did better in protecting their residents from mortality during all periods of the SARS-CoV-2 pandemic and even before vaccination. Perhaps higher GDP per capita contributed to their better performance throughout the pandemic. During mass vaccination, when the Delta variant prevailed, the contrast in mortality rates between the “faster” and “slower” categories was strongest. The average excess mortality in the “slower” countries was nearly 5 times higher than in the “faster” countries, and the odds ratio (OR) was 4.9 (95% CI 4.4 to 5.4). Slower booster rates were associated with significantly higher mortality during periods dominated by Omicron BA.1 and BA.2, with an OR of 2.6 (CI 95%. 2.1 to 3.3). Among the European countries we analyzed, Denmark, Norway, and Ireland did best, with a pandemic mortality rate of 0.1% of the population or less. By comparison, Bulgaria, Serbia, and Russia had a much higher mortality rate of up to 1% of the population. CONCLUSION: Thus, slow vaccination and booster administration was a major factor contributing to an order of magnitude higher excess mortality in “slower” European countries compared to more rapidly immunized countries.
format Online
Article
Text
id pubmed-10357837
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103578372023-07-21 Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries Matveeva, Olga Shabalina, Svetlana A. Front Immunol Immunology AIM: To evaluate the effect of vaccination/booster administration dynamics on the reduction of excess mortality during COVID-19 infection waves in European countries. METHODS: We selected twenty-nine countries from the OurWorldInData project database according to their population size of more than one million and the availability of information on dominant SARS-CoV-2 variants during COVID-19 infection waves. After selection, we categorized countries according to their “faster” or “slower” vaccination rates. The first category included countries that reached 60% of vaccinated residents by October 2021 and 70% by January 2022. The second or “slower” category included all other countries. In the first or “faster” category, two groups, “boosters faster’’ and “boosters slower” were created. Pearson correlation analysis, linear regression, and chi-square test for categorical data were used to identify the association between vaccination rate and excess mortality. We chose time intervals corresponding to the dominance of viral variants: Wuhan, Alpha, Delta, and Omicron BA.1/2. RESULTS AND DISCUSSION: The “faster” countries, as opposed to the “slower” ones, did better in protecting their residents from mortality during all periods of the SARS-CoV-2 pandemic and even before vaccination. Perhaps higher GDP per capita contributed to their better performance throughout the pandemic. During mass vaccination, when the Delta variant prevailed, the contrast in mortality rates between the “faster” and “slower” categories was strongest. The average excess mortality in the “slower” countries was nearly 5 times higher than in the “faster” countries, and the odds ratio (OR) was 4.9 (95% CI 4.4 to 5.4). Slower booster rates were associated with significantly higher mortality during periods dominated by Omicron BA.1 and BA.2, with an OR of 2.6 (CI 95%. 2.1 to 3.3). Among the European countries we analyzed, Denmark, Norway, and Ireland did best, with a pandemic mortality rate of 0.1% of the population or less. By comparison, Bulgaria, Serbia, and Russia had a much higher mortality rate of up to 1% of the population. CONCLUSION: Thus, slow vaccination and booster administration was a major factor contributing to an order of magnitude higher excess mortality in “slower” European countries compared to more rapidly immunized countries. Frontiers Media S.A. 2023-07-06 /pmc/articles/PMC10357837/ /pubmed/37483606 http://dx.doi.org/10.3389/fimmu.2023.1151311 Text en Copyright © 2023 Matveeva and Shabalina https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Matveeva, Olga
Shabalina, Svetlana A.
Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries
title Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries
title_full Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries
title_fullStr Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries
title_full_unstemmed Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries
title_short Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries
title_sort comparison of vaccination and booster rates and their impact on excess mortality during the covid-19 pandemic in european countries
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357837/
https://www.ncbi.nlm.nih.gov/pubmed/37483606
http://dx.doi.org/10.3389/fimmu.2023.1151311
work_keys_str_mv AT matveevaolga comparisonofvaccinationandboosterratesandtheirimpactonexcessmortalityduringthecovid19pandemicineuropeancountries
AT shabalinasvetlanaa comparisonofvaccinationandboosterratesandtheirimpactonexcessmortalityduringthecovid19pandemicineuropeancountries